Efficacy and Cost-effectiveness of Dabigatran Etexilate versus Warfarin in Atrial Fibrillation (AF) in Different Age Subgroups: A United States Perspective

Autoren

Clemens A, Peng S, Brand S, Brueckmann M, Kansal A, Lim J, Noack H, Sanders S, Sorensen S

Abstract